Treatment of hypertension in the elderly

I. Blood pressure and clinical changes. Results of a department of veterans affairs cooperative study

Barry J. Materson, William Cushman, Gerald Goldstein, Domenic J. Reda, Edward D. Freis, Eli A. Ramirez, Frederick N. Talmers, Thomas J. White, Stewart Nunn, Robert H. Chapman, Ibrahim Khatri, Harold Schnaper, J. R. Thomas, William G. Henderson, Carol Fye

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

We compared the efficacy and adverse effects of antihypertensive drug regimens in 690 men past age 60 with diastolic blood pressure 90-114 mm Hg and systolic blood pressure less than 240 mm Hg. They received either a low (25-50 mg) or high (50-100 mg) dose of hydrochlorothiazide daily. Of 644 patients who completed the hydrochlorothiazide titration, 375 (58.2%) were responders (diastolic blood pressure <90 and ≤5 mm Hg below baseline) and 92.8% of these completed a 6-month maintenance period. Blood pressure was reduced from 157.6/98.5 mm Hg by 18.3/9.5 mm Hg with low dose hydrochlorothiazide and by 20.4/9.6 mm Hg with high dose hydrochlorothiazide; more patients achieved goal blood pressure with the high dose. Whites and blacks responded equally. Serum potassium less than 3.5 mmol/l occurred in 104 of 321 (32.3%) of the high dose versus 62 of 333 (18.6%) of the low dose hydrochlorothiazide patients. The 269 nonresponders to hydrochlorothiazide were randomly assigned in a double-blind study to receive hydralazine, methyldopa, metoprolol, or reserpine in addition to hydrochlorothiazide; 79.2% responded to the addition of the second drug and 87.3% of these completed a 6-month maintenance phase. Overall, there were no significant efficacy differences among the step 2 regimens. We conclude that the lower dose of hydrochlorothiazide was nearly as effective as the higher dose, and the addition of a second drug was effective and generally well tolerated in elderly patients.

Original languageEnglish (US)
Pages (from-to)348-360
Number of pages13
JournalHypertension
Volume15
Issue number4
DOIs
StatePublished - Jan 1 1990

Fingerprint

Hydrochlorothiazide
Veterans
Blood Pressure
Hypertension
Therapeutics
Maintenance
Methyldopa
Hydralazine
Metoprolol
Reserpine
Double-Blind Method
Pharmaceutical Preparations
Antihypertensive Agents
Potassium
Serum

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Treatment of hypertension in the elderly : I. Blood pressure and clinical changes. Results of a department of veterans affairs cooperative study. / Materson, Barry J.; Cushman, William; Goldstein, Gerald; Reda, Domenic J.; Freis, Edward D.; Ramirez, Eli A.; Talmers, Frederick N.; White, Thomas J.; Nunn, Stewart; Chapman, Robert H.; Khatri, Ibrahim; Schnaper, Harold; Thomas, J. R.; Henderson, William G.; Fye, Carol.

In: Hypertension, Vol. 15, No. 4, 01.01.1990, p. 348-360.

Research output: Contribution to journalArticle

Materson, BJ, Cushman, W, Goldstein, G, Reda, DJ, Freis, ED, Ramirez, EA, Talmers, FN, White, TJ, Nunn, S, Chapman, RH, Khatri, I, Schnaper, H, Thomas, JR, Henderson, WG & Fye, C 1990, 'Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a department of veterans affairs cooperative study', Hypertension, vol. 15, no. 4, pp. 348-360. https://doi.org/10.1161/01.HYP.15.4.348
Materson, Barry J. ; Cushman, William ; Goldstein, Gerald ; Reda, Domenic J. ; Freis, Edward D. ; Ramirez, Eli A. ; Talmers, Frederick N. ; White, Thomas J. ; Nunn, Stewart ; Chapman, Robert H. ; Khatri, Ibrahim ; Schnaper, Harold ; Thomas, J. R. ; Henderson, William G. ; Fye, Carol. / Treatment of hypertension in the elderly : I. Blood pressure and clinical changes. Results of a department of veterans affairs cooperative study. In: Hypertension. 1990 ; Vol. 15, No. 4. pp. 348-360.
@article{85f526b1cc454442bfd9984204efcfa7,
title = "Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a department of veterans affairs cooperative study",
abstract = "We compared the efficacy and adverse effects of antihypertensive drug regimens in 690 men past age 60 with diastolic blood pressure 90-114 mm Hg and systolic blood pressure less than 240 mm Hg. They received either a low (25-50 mg) or high (50-100 mg) dose of hydrochlorothiazide daily. Of 644 patients who completed the hydrochlorothiazide titration, 375 (58.2{\%}) were responders (diastolic blood pressure <90 and ≤5 mm Hg below baseline) and 92.8{\%} of these completed a 6-month maintenance period. Blood pressure was reduced from 157.6/98.5 mm Hg by 18.3/9.5 mm Hg with low dose hydrochlorothiazide and by 20.4/9.6 mm Hg with high dose hydrochlorothiazide; more patients achieved goal blood pressure with the high dose. Whites and blacks responded equally. Serum potassium less than 3.5 mmol/l occurred in 104 of 321 (32.3{\%}) of the high dose versus 62 of 333 (18.6{\%}) of the low dose hydrochlorothiazide patients. The 269 nonresponders to hydrochlorothiazide were randomly assigned in a double-blind study to receive hydralazine, methyldopa, metoprolol, or reserpine in addition to hydrochlorothiazide; 79.2{\%} responded to the addition of the second drug and 87.3{\%} of these completed a 6-month maintenance phase. Overall, there were no significant efficacy differences among the step 2 regimens. We conclude that the lower dose of hydrochlorothiazide was nearly as effective as the higher dose, and the addition of a second drug was effective and generally well tolerated in elderly patients.",
author = "Materson, {Barry J.} and William Cushman and Gerald Goldstein and Reda, {Domenic J.} and Freis, {Edward D.} and Ramirez, {Eli A.} and Talmers, {Frederick N.} and White, {Thomas J.} and Stewart Nunn and Chapman, {Robert H.} and Ibrahim Khatri and Harold Schnaper and Thomas, {J. R.} and Henderson, {William G.} and Carol Fye",
year = "1990",
month = "1",
day = "1",
doi = "10.1161/01.HYP.15.4.348",
language = "English (US)",
volume = "15",
pages = "348--360",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Treatment of hypertension in the elderly

T2 - I. Blood pressure and clinical changes. Results of a department of veterans affairs cooperative study

AU - Materson, Barry J.

AU - Cushman, William

AU - Goldstein, Gerald

AU - Reda, Domenic J.

AU - Freis, Edward D.

AU - Ramirez, Eli A.

AU - Talmers, Frederick N.

AU - White, Thomas J.

AU - Nunn, Stewart

AU - Chapman, Robert H.

AU - Khatri, Ibrahim

AU - Schnaper, Harold

AU - Thomas, J. R.

AU - Henderson, William G.

AU - Fye, Carol

PY - 1990/1/1

Y1 - 1990/1/1

N2 - We compared the efficacy and adverse effects of antihypertensive drug regimens in 690 men past age 60 with diastolic blood pressure 90-114 mm Hg and systolic blood pressure less than 240 mm Hg. They received either a low (25-50 mg) or high (50-100 mg) dose of hydrochlorothiazide daily. Of 644 patients who completed the hydrochlorothiazide titration, 375 (58.2%) were responders (diastolic blood pressure <90 and ≤5 mm Hg below baseline) and 92.8% of these completed a 6-month maintenance period. Blood pressure was reduced from 157.6/98.5 mm Hg by 18.3/9.5 mm Hg with low dose hydrochlorothiazide and by 20.4/9.6 mm Hg with high dose hydrochlorothiazide; more patients achieved goal blood pressure with the high dose. Whites and blacks responded equally. Serum potassium less than 3.5 mmol/l occurred in 104 of 321 (32.3%) of the high dose versus 62 of 333 (18.6%) of the low dose hydrochlorothiazide patients. The 269 nonresponders to hydrochlorothiazide were randomly assigned in a double-blind study to receive hydralazine, methyldopa, metoprolol, or reserpine in addition to hydrochlorothiazide; 79.2% responded to the addition of the second drug and 87.3% of these completed a 6-month maintenance phase. Overall, there were no significant efficacy differences among the step 2 regimens. We conclude that the lower dose of hydrochlorothiazide was nearly as effective as the higher dose, and the addition of a second drug was effective and generally well tolerated in elderly patients.

AB - We compared the efficacy and adverse effects of antihypertensive drug regimens in 690 men past age 60 with diastolic blood pressure 90-114 mm Hg and systolic blood pressure less than 240 mm Hg. They received either a low (25-50 mg) or high (50-100 mg) dose of hydrochlorothiazide daily. Of 644 patients who completed the hydrochlorothiazide titration, 375 (58.2%) were responders (diastolic blood pressure <90 and ≤5 mm Hg below baseline) and 92.8% of these completed a 6-month maintenance period. Blood pressure was reduced from 157.6/98.5 mm Hg by 18.3/9.5 mm Hg with low dose hydrochlorothiazide and by 20.4/9.6 mm Hg with high dose hydrochlorothiazide; more patients achieved goal blood pressure with the high dose. Whites and blacks responded equally. Serum potassium less than 3.5 mmol/l occurred in 104 of 321 (32.3%) of the high dose versus 62 of 333 (18.6%) of the low dose hydrochlorothiazide patients. The 269 nonresponders to hydrochlorothiazide were randomly assigned in a double-blind study to receive hydralazine, methyldopa, metoprolol, or reserpine in addition to hydrochlorothiazide; 79.2% responded to the addition of the second drug and 87.3% of these completed a 6-month maintenance phase. Overall, there were no significant efficacy differences among the step 2 regimens. We conclude that the lower dose of hydrochlorothiazide was nearly as effective as the higher dose, and the addition of a second drug was effective and generally well tolerated in elderly patients.

UR - http://www.scopus.com/inward/record.url?scp=0025195160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025195160&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.15.4.348

DO - 10.1161/01.HYP.15.4.348

M3 - Article

VL - 15

SP - 348

EP - 360

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -